Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06332040 · ClinicalTrials.gov registry record · Phase 4
Gentamicin Bladder Instillation on CAUTI
A Phase 4 study of Catheter Infection, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT06332040 is a Phase 4 study of Catheter Infection that is actively recruiting participants, run by St. Joseph's Hospital and Medical Center, Phoenix. The registered enrollment target is 400 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06332040, a Phase 4 study of Catheter Infection, is actively recruiting participants, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
Urinary tract infections in catheterized patients is an unacceptable complication and has been termed a 'never event' by the Center for Medicare \& Medicaid Services (CMS); however there is not consensus among clinicians on how to best prevent CAUTIs. We propose a prospective randomized controlled trial to test the efficacy of prophylactic gentamicin bladder irrigation in elimination of CAUTIs.
Conditions Studied
Interventions
- DRUG Gentamicin
Study Locations (1)
Arizona
- St. Jpseph's Hospital and Medical Center - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2023-10-09 |
| Est. Completion | 2026-10-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06332040
The ClinicalTrials.gov registry entry for NCT06332040 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Joseph's Hospital and Medical Center, Phoenix, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Catheter Infection appearing as the primary indexed condition, and to 1 intervention - of which Gentamicin is the first listed.
NCT06332040 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT06332040 about?
NCT06332040 is a clinical study titled "Gentamicin Bladder Instillation on CAUTI". Urinary tract infections in catheterized patients is an unacceptable complication and has been termed a 'never event' by the Center for Medicare \& Medicaid Services (CMS); however there is not consensus among clinicians on how to best prevent CAUTIs. We propose a prospective randomized controlled t...
What is the current status of trial NCT06332040?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 400 participants. The study started on 2023-10-09. Estimated completion is 2026-10-08.
What conditions does trial NCT06332040 study?
This clinical trial studies the following conditions: Catheter Infection.
What interventions are being tested in trial NCT06332040?
The interventions under investigation include: Gentamicin (DRUG).
Who is sponsoring clinical trial NCT06332040?
This trial is sponsored by St. Joseph's Hospital and Medical Center, Phoenix, which has 44 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06332040 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Catheter Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.